Federal contract award
75F40123F19051
CALL ORDER UNDER THE FDA'S INTEGRATED SERVICES BLANKET PURCHASE AGREEMENT FOR EXECUTIVE COACHING PROGRAM SERVICES FOR THE CENTER FOR DRUG EVALUATION AND RESEARCH (CDER), OFFICE OF PHARMACEUTICAL QUALITY (OPQ).
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541611 — Administrative Management and General Management Consulting Services |
| PSC | R410 — SUPPORT- PROFESSIONAL: PROGRAM EVALUATION/REVIEW/DEVELOPMENT |
| Parent award / vehicle | 75F40119A10003 |
| Set-aside | Not reported |
| Pricing type | LABOR HOURS |
| Obligations | $387.6K |
| Current contract value | $387.6K |
| Potential contract value / ceiling | $387.6K |
| Start date | Sep 13, 2023 |
| Current end date | Apr 30, 2025 |
| Potential end date | Apr 30, 2025 |
| Latest award activity | May 21, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 4 of 4 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| May 21, 2026 | P00006 | $-88.0K | EOI::DEFEND THE SPEND::EOI FULL TERMINATION FOR CONVENIENCE NO-COST SETTLEMENT AGREEMENT |
| Jun 12, 2025 | P00005 | $0 | EXECUTIVE COACHING PROGRAM SERVICES FOR THE CENTER FOR DRUG EVALUATION AND RESEARCH, OFFICE OF PHARMACEUTICAL QUALITY. |
| Apr 30, 2025 | P00004 | $0 | EOI::EXECUTIVE ORDER 14222, IMPLEMENTING THE PRESIDENT'S "DEPARTMENT OF GOVERNMENT EFFICIENCY" COST EFFICIENCY INITIATIVE (FEBRUARY 26, 2025)::EOI NOTICE OF TERMINATION FOR CONVENIENCE (FULL) |
| Apr 16, 2025 | P00003 | $0 | CALL ORDER UNDER THE FDA'S INTEGRATED SERVICES BLANKET PURCHASE AGREEMENT FOR EXECUTIVE COACHING PROGRAM SERVICES FOR THE CENTER FOR DRUG EVALUATION AND RESEARCH (CDER), OFFICE OF PHARMACEUTICAL QUALITY (OPQ). |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.